Update on Credit Rating

Sun Pharmaceutical Industries Limited SUN HOUSE, Plot No. 201 B/1, Western Express Highway, Goregaon (E), Mumbai 400063, India Tel.: (91-22) 4324 4324 Fax.: (91-22) 4324 4343 Website: www.sunpharma.com Email: secretarial@sunpharma.com CIN: L24230GJ1993PLC019050 05 August 2026 National Stock Exchange of India Limited BSE Limited Scrip Symbol: SUNPHARMA Scrip Code: 524715 Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 – Update on Credit Rating This is with reference to our earlier communication dated 07 May 2026, wherein we had informed that CRISIL Ratings Limited (“CRISIL”) had reaffirmed the rating on the long-term bank facilities of Sun Pharmaceutical Industries Limited (“Company”) at ‘CRISIL AAA’ and had placed the said rating on ‘Rating Watch with Developing Implications’ following the Company’s announcement dated 27 April 2026. CRISIL has now removed the ‘Rating Watch with Developing Implications’ status and has reaffirmed the rating assigned to the Company's long-term bank facilities at ‘CRISIL AAA/Stable’ (Reaffirmed; Removed from ‘Rating Watch with Developing Implications’). For Sun Pharmaceutical Industries Limited (Anoop Deshpande) Company Secretary and Compliance Officer ICSI Membership No.: A23983 Registered Office: SPARC, Tandalja, Vadodara – 390 012, Gujarat, INDIA Reaching People. Touching Lives